---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-26-000041"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2026-08-03T21:01:56+00:00"
generated_at: "2026-08-03T21:04:17.662683+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Viemed Q2 2026 revenue $78.1M record, up 23.9% YoY; raises FY revenue guidance

## Summary
- Net revenue $78.1M (record), up 23.9% YoY; net income $2.8M ($0.07 diluted EPS).
- Adjusted EBITDA $13.7M, down 4% YoY due to prior-year non-recurring gain of $1.0M.
- Ventilator patients 12,635 (+4% YoY); PAP therapy patients 37,825 (+44% YoY).
- Repurchased 530,802 shares at avg $9.65 for $5.1M in Q2.
- FY 2026 revenue guidance raised to $314-320M (prev $312-320M); Adj. EBITDA guidance narrowed to $64-68M (prev $65-69M).

## SEC filing metadata
- accession: 0001729149-26-000041
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2026-08-03T21:01:56+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/0001729149-26-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914926000041/vmd-20260803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-26-000041
- JSON: https://secwatch.observer/filing/0001729149-26-000041.json
- Plain text: https://secwatch.observer/filing/0001729149-26-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.